Rare diseases
Investigational molecules
Locations
NHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
BulgariaTelisotuzumab Adizutecan for Locally Advanced or Metastatic Solid Tumors with MET Amplification in Patients 12 Years and Older
DenmarkLong-Term Safety Study of Asciminib in Patients With Chronic Myelogenous Leukemia or Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
AustriaBelatacept Dose Reduction Safety in Kidney Transplant Recipients with a Well-Matched Donor
AustriaEIK1005 Alone and with Pembrolizumab for Advanced Solid Tumors in Patients with MSI-H or dMMR Tumors
AustriaAUR200 for Patients with Generalized Myasthenia Gravis
DenmarkPumitamig Versus Pembrolizumab in Patients With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%
AustriaNeoadjuvant Sacituzumab Govitecan and Pembrolizumab for Patients with Clinical Stage II-III Triple-Negative Early Breast Cancer
GermanyStudy of Tirabrutinib, Rituximab, and Temozolomide in Patients with Relapsed/Refractory Primary Central Nervous System Lymphoma
AustriaDermatophagoides farinae, Dermatophagoides pteronyssinus, and Lepidoglyphus destructor Immunotherapy for Allergic Rhinitis and Rhinoconjunctivitis in Patients With or Without Mild Asthma
SpainLetrozole During IVF/ICSI for Women with Endometriosis
BelgiumQTX-2101 and Arsenic Trioxide in Adult Patients With Acute Promyelocytic Leukemia
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
